BioNTech SE BNTX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.97B | -1.45B | -1.26B | -633.26M | -381.92M |
| Total Depreciation and Amortization | 558.56M | 306.94M | 210.06M | 273.71M | 177.32M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 943.28M | 933.99M | 1.04B | -32.19M | -306.93M |
| Change in Net Operating Assets | 1.26B | 1.16B | 628.56M | 155.31M | -1.34B |
| Cash from Operations | 792.65M | 946.71M | 617.72M | -236.43M | -1.85B |
| Capital Expenditure | -245.50M | -212.76M | -197.76M | -195.18M | -233.24M |
| Sale of Property, Plant, and Equipment | 9.92M | 6.53M | 5.18M | 5.23M | 2.17M |
| Cash Acquisitions | 308.25M | 308.25M | 225.64M | -82.61M | -82.61M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.34B | -1.33B | -3.05B | 1.08B | 2.04B |
| Cash from Investing | -1.27B | -1.23B | -3.02B | 803.92M | 1.73B |
| Total Debt Issued | 82.90M | 45.10M | 6.70M | -- | -- |
| Total Debt Repaid | -59.60M | -55.80M | -57.60M | -45.90M | -42.30M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -129.20M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00M | -2.00M | -2.00M | -- | -- |
| Cash from Financing | -125.40M | -14.30M | -59.71M | -50.84M | -46.08M |
| Foreign Exchange rate Adjustments | -31.32M | -17.04M | -30.01M | -17.14M | 5.47M |
| Miscellaneous Cash Flow Adjustments | 31.38M | 35.38M | 8.16M | -18.45M | 23.37M |
| Net Change in Cash | -602.52M | -275.75M | -2.48B | 481.05M | -139.33M |